Seaport Therapeutics, Inc. (NasdaqGS: SPTX)
Salud · Farmacéuticas · US
18,17 $
-4,97 % hoy · -8,4 % 1 año
Seaport Therapeutics, Inc. (NasdaqGS: SPTX) opera en la industria de farmacéuticas dentro del sector salud. Su valor en bolsa es de 972,65 M $ y tiene 58 empleados.
En los últimos doce meses la acción ha bajado un 8,4 % y ha cotizado entre 14,85 y 28,38.
Tweenvest puntúa a Seaport Therapeutics, Inc. en cuatro factores: calidad 51/100, valor 100/100. Su punto más fuerte es valor.
Evolución de la cotización de SPTX
Cifras clave
- Capitalización
- 972,65 M $
- Ingresos (últ. 12 m)
- —
- PER
- -12,99
- BPA
- -10,04
- Rent. por dividendo
- —
- Beta (5 años)
- —
- Máximo 52 semanas
- 28,38 $
- Mínimo 52 semanas
- 14,85 $
- Volumen medio (3 m)
- —
- Acciones en circulación
- 53,53 M
- Empleados
- 58
- Próximos resultados
- —
Sobre Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
- ISIN
- US81221K1088
- Fundada en
- 2024
- Cotiza desde
- 1 may 2026
- Bolsa
- Nasdaq Global Select
- Divisa
- USD
Otras empresas de farmacéuticas
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| Aarti Pharmalabs LimitedNSEI: AARTIPHARM | 985,98 M $ | 1015,90 Rs | +2,95 % |
| Guangxi Wuzhou Zhongheng Group Co., LtdSHSE: 600252 | 982,61 M $ | 2,07 CN¥ | -2,36 % |
| HARBIN GLORIA PHARMACEUTICALS Co., LTDSZSE: 002437 | 978,70 M $ | 2,93 CN¥ | -3,62 % |
| Procter & Gamble Health LimitedBSE: 500126 | 977,57 M $ | 5503,25 Rs | +0,57 % |
| KPC Pharmaceuticals,Inc.SHSE: 600422 | 948,05 M $ | 8,36 CN¥ | -1,07 % |
| Mega Lifesciences Public Company LimitedSET: MEGA | 942,06 M $ | 36,60 ฿ | 0,00 % |
| China Animal Husbandry Industry Co., Ltd.SHSE: 600195 | 934,70 M $ | 6,11 CN¥ | +0,49 % |
| SSY Group LimitedSEHK: 2005 | 928,65 M $ | 2,52 HK$ | -0,59 % |